In a report released today, Jonathan Block from Stifel Nicolaus maintained a Buy rating on Idexx Laboratories (IDXX), with a price target of $375.00. The company’s shares closed last Thursday at $374.10.
According to TipRanks.com, Block is a 5-star analyst with an average return of 11.7% and a 65.1% success rate. Block covers the Healthcare sector, focusing on stocks such as SmileDirectClub, Align Tech, and Intricon.
Idexx Laboratories has an analyst consensus of Strong Buy, with a price target consensus of $318.60.
See today’s analyst top recommended stocks >>
Idexx Laboratories’ market cap is currently $31.16B and has a P/E ratio of 72.30. The company has a Price to Book ratio of -167.40.
Based on the recent corporate insider activity of 79 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of IDXX in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. It operates through the following segments: CAG, Water, LPD, and Other. The CAG segment develops, designs, manufactures, and distributes products and performs services for veterinarians and the biomedical analytics market, primarily related to diagnostics and information management. The Water segment develops, designs, manufactures, and distributes a range of products used in the detection of various microbiological parameters in water. The LPD segment develops, designs, manufactures, and distributes diagnostic tests and related instrumentation and performs services, which are used to manage the health status of livestock and poultry, to improve producer, and to ensure the quality and safety of milk and food. The Other operating segment combines and presents products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983 and is headquartered in Westbrook, ME.
Read More on IDXX:
